Hospira Injectable Drug Products: Recall – Visible Particulates from Defective Glass Vials

by FDA on July 16, 2012

in MedWatch

Symptoms of particulate matter injected into a patient might include bleeding, bruising, inflammation, itching, rash, chest pain and respiratory symptoms.

This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The link below will take you to the original notice.

View Full Details Of The Original MedWatch Notice Here.

Leave a Comment

Previous post:

Next post: